Capreomycin, ethambutol and rifampicin in apparently incurable pulmonary tuberculosis.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity; D004802:Eosinophilia / Q000139:chemically induced; D004977:Ethambutol / Q000627:therapeutic use*; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014527:Uric Acid / Q000097:blood; D014786:Vision Disorders / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D014527:Uric Acid; D004977:Ethambutol; D012293:Rifampin